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Headache as a predictor for dementia: The
HUNT Study
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Background: The impact of headache on dementia is largely unknown. This study examined the association
between headache and dementia using data from a large population-based study.
Methods: This population-based study used data from the Nord-Trøndelag Health Surveys performed in 1995–1997
(HUNT2) and 2006–2008 (HUNT3). The reference group (controls) was participants aged ≥55 years who answered
the headache questions in HUNT2 and later participated in HUNT3 (n = 15,601). The association with headache
status in HUNT2 was investigated in sample of confirmed non-demented elderly evaluated with psychometric tests
after HUNT3 (n = 96), and HUNT2 participants later diagnosed with dementia during 1997–2011 (n = 746). The
association with headache was evaluated by logistical regression with adjustment for age, gender, level of
education, comorbidity, smoking, and anxiety and depression.
Results: Any headache was more likely to be reported in HUNT2 among those who later were included in the
dementia registry (OR 1.24; 95 % CI 1.04–1.49) compared to the reference group, but less likely among the
confirmed non-demented individuals (OR 0.62; 95 % CI 0.39–0.98). This relationship was even stronger for
non-migrainous headache, whereas such association was not found for migraine.
Conclusions: Compared to the reference group, individuals with dementia were more likely to report non-previous
migrainous headache in HUNT2, whereas a sample of confirmed non-demented were less likely to report previous
non-migrainous headache.
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Background
Headache is a common disorder affecting approximately
46 % of the adult population and is the third highest
cause of disability worldwide [1, 2]. The prevalence of
headache decreases distinctly after 50 years of age, but it
is still a common complaint in the elderly population
[3, 4]. Among middle-aged or elderly headache patients a
large number of comorbid conditions have been identified,
e.g., psychiatric disorders [5–8]. However, relatively few
studies have evaluated the relationship between head-
ache and cognitive status and dementia, and the ma-
jority of previous studies have focused on migraine
[9–16]. Although a Swedish registry study reported an
association between migraine and the occurrence of
dementia with Lewy bodies [16], most other studies
have not found any relationship between migraine and
cognitive decline [9–15].
In a longitudinal Norwegian population-based study we
have previously reported that headache at baseline was as-
sociated with slightly higher risk of dementia [17]. In that
study, individuals not included in a dementia registry were
classified as non-demented because they had managed to
answer two questionnaires and a personal interview. No
specific cognitive tests were performed. After that study
was published, the dementia registry has been expanded
with about 50 % more individuals, and in addition, we
have new data including a group of definitely non-
demented aged 55–89 years, verified by performance on
tests of memory and intelligence.
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The purpose of the present population-based study
was to evaluate the association between primary head-
ache and the development of dementia versus later be-
longing to a group of confirmed non-demented elderly,
using a large group of health survey participants as ref-
erence group.
Methods
Study population
All inhabitants of Nord-Trøndelag county in Norway
20 years and older have been invited to three surveys,
HUNT1 (1984–1986), HUNT2 (1995–1997), and HUNT3
(2006–2008) [18]. The overall participation rate has been
90 % for HUNT1, 70 % for HUNT2, and 54 % for
HUNT3, respectively [18]. In all three surveys participants
were asked to complete two extensive questionnaires (Q1
and Q2) including more than 200 health-related items,
and they were also invited to a brief medical examination.
Among respondents of Q1, approximately 80 % have also
completed Q2 (i.e., 20 % Q2 dropouts).
The present study used data from HUNT2 and HUNT3.
Among 92,938 invited individuals in HUNT2, 64,787
(70 %) answered Q1, of whom 52,230 (56 %) answered
the headache questions in Q2. Details of nonresponders
have been described previously [3]. Individuals who
responded to the headache questions were younger, were
more likely to be women and had higher socioeconomic
status than nonreponders [3]. Among responders, a total
of 6608 had died and 3009 had moved from Nord-
Trøndelag prior to HUNT3. Of 42,541 eligible, 26,197
(62 %) individuals also participated and completed all
questionnaires in HUNT3. Among these, 15,697 were in
the age interval 55–89 years at HUNT3 and therefore
eligible for the present study (Fig. 1).
The sample of confirmed non-demented
The sample was originally selected from the HUNT3 re-
search Centre database for a separate study that originally
had the aim to find a healthy Norwegian sample for test-
ing translations of the Wechsler Memory Scale-III and the
Wechsler Adult Intelligence Scale-III, to establish whether
published American norms and principles for interpret-
ation could be used in Norwegian clinical practice [19].
Based on information provided by the database, the
HUNT research centre picked out 180 presumably healthy
individuals, 30 in each age group (55–64, 65–69, 70–74,
75–79, 80–84 and 85–89 years old). The exclusion
criteria were a) known disease in the central nervous
Fig. 1 Flow diagram of the study population
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system, b) known severe psychiatric illness c) known
abuse of alcohol/other stimulants, d) severely impaired
vision/hearing, e) impaired mobility to a degree that com-
plicated execution of testing. Each invited individual was
interviewed before testing, and asked questions about any
mental or physical disease that might affect their cogni-
tion, or make it difficult to accomplish the testing. The
sample therefore consists of presumably healthy individ-
uals. Out of the 124 invited who consented to participate,
a total of 122 persons (66 %) aged 57–89 years (M= 74.2;
SD 8.8), with 7–21 years of education (M= 10.7; SD 3.2)
were included. Of these, 52.5 % were women. In accord-
ance with population data from Statistics Norway [20], the
number of women was highest in the oldest age group,
average education level lower in the oldest age group and
lower for women than men in all age groups. Two individ-
uals were excluded due to known degenerative brain or-
ganic illness revealed through questioning on health
condition prior to the testing. Among the 122 evaluated
with tests of memory and intelligence, 96 of confirmed
non-demented had previously answered the headache
questionnaire in HUNT2 (Fig. 1).
Confirmed with dementia
This study includes data from the Dementia registry
established through the Health and Memory Study
(HMS), from which the dementia diagnoses were ob-
tained. Data for the HMS were collected through two pro-
cedures. First, during the period 2008–2010, patient files
from 1998 to 2010 in the two hospitals in Nord-Trøndelag
county (Namsos Hospital and Levanger Hospital) were ex-
amined to identify those who had been registered with a
diagnosis of dementia. Secondly, during 2010–2011, all in-
habitants residing in nursing homes in Nord-Trøndelag
were invited to participate in an extensive health examin-
ation focused on dementia diagnoses and related variables,
using standardized interviews to assess cognitive decline
and dementia. A total of 1332 dementia cases were identi-
fied: 104 from both hospital and nursing home files, 727
from only hospital files, and 501 from only nursing home
files. The hospital cases were diagnosed by clinical experts
in dementia, consisting of an internist (geriatrican) and
two psychogeriatrists. The diagnoses were made according
to national and international guidelines. More details of
the distribution of dementia diagnoses identified in hos-
pital are published elsewhere [17, 21]. The nursing home
data were collected by nurses with adequate clinical ex-
perience [21]. In addition, two physicians with wide clin-
ical and research experience independently diagnosed
dementia subtypes using all available information. If the
two physicians disagreed about diagnosis, a third expert
was consulted to reach consensus [21]. The distribution of
dementia diagnoses identified in nursing homes is pub-
lished elsewhere [21].
The dementia registry was linked to data from the
HUNT study using the Norwegian 11-digit personal
identity number, which is unique to each resident in
Norway. A total of 746 (56 %) had answered the head-
ache questions in HUNT2 (Fig. 1), whereof 378 were
identified from hospitals by a diagnostic hospital team
[17], the remaining 368 by a nursing home team [21].
Because the diagnostic procedure and validity of diagno-
ses regarding dementia with Lewy body and frontotem-
poral dementia were somewhat different in the hospital
and nursing home as described above, we have simplified
the diagnostic categories of dementia into four different
groups; Alzheimer’s disease (AD), vascular dementia
(VaD), mixed dementia (AD +VaD), and lastly all other
types of dementia (including dementia with Lewy body,
frontotemporal dementia, and mild cognitive impairment).
Headache diagnoses
Subjects who answered yes to the screening question “Have
you suffered from headache during the last 12 months?” in
Q2 were classified as having “any headache” and the
remaining as headache free. Based on the subsequent 12
headache questions, headache sufferers were classified by
applying modified migraine criteria of the International
Classification of Headache Disorders, first edition (ICHD-I)
[22]. Headache that did not fulfil the criteria for migraine
was classified as non-migrainous headache. Migraine and
non-migrainous headache were also categorized according
to frequency (1–14 days or ≥ 15 days per month).
The validity of these questionnaire-based diagnoses has
been reported previously [23]: for any headache, sensitivity
was 85 % and specificity 83 % (kappa value 0.57); for mi-
graine, sensitivity was 69 % and specificity 89 % (kappa
value 0.59); and for non-migrainous headache, sensitivity
was 61 %, specificity 81 % (kappa 0.43) [23]. In the valid-
ation study, 80 % of individuals with non-migrainous
headache suffered from tension-type headache [23].
Study design
In this population-based study the reference group were
participants aged ≥55 years who answered the headache
questions in HUNT2 and later participated in HUNT3.
The reference group association was compared with
HUNT2-participants who later were included in a group
of confirmed non-demented elderly evaluated with psy-
chometric tests after HUNT3, and with HUNT2 partici-
pants who later were diagnosed with dementia during
1997–2011.
Potential confounders
In the HUNT2 data file the following seven variables
were available: 1) Educational level (categorized accord-
ing to duration: < 9 years, 10–12 years or > 13 years); 2)
Anxiety and depression assessed by the Hospital Anxiety
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and Depression Scale (total HADS score); 3) Smoking
(current, previous, or never); 4) Body mass index (BMI);
5) Systolic blood pressure (BP); 6) Physical activity cate-
gorized according to the response to two questions
about duration and intensity of exercise per week (≥3 h’
hard physical activity, 1–2 h’ hard physical activity, ≥3 h’
light physical activity, 1–2 h’ light physical activity, or
physical inactivity, 0 h); and 7) Presence of severe co-
morbidity based on the inclusion and exclusion criteria
for individuals selected to the normative study of mem-
ory and intelligence 19] (severe visual and/or auditory
problems, severe psychiatric problems, score of ≥ 1 on
the CAGE questionnaire indicating possible alcohol
overuse and/or self-reported stroke).
Statistical analysis
We evaluated the association between headache in
HUNT2 and later development of dementia or status of
confirmed non-demented elderly by multivariate ana-
lyses using logistic regression with 95 % confidence in-
tervals (CI). The analyses were initially adjusted for age
and gender only. Subsequently, additional adjustments
for other potential confounding factors were performed
separately or together, but these factors were excluded
from the final analyses if the OR changed less than 0.05.
In the final multivariate analyses we adjusted for age
(continuous variable), education (three categories), total
Hospital and Anxiety and Depression (HADS) score
(three categories), severe comorbid condition (two cat-
egories), and smoking (three categories). Other potential
confounding factors evaluated, but not included in the
final analyses were: BMI, smoking, Systolic BP and phys-
ical activity. Statistical analyses were performed with the
Predictive Analytics Software (PASW) Statistics version
22 by SPSS Inc, an IBM Company (Chicago, IL, USA).
Ethics
This study was approved by the Regional Committee for
Ethics in Medical Research (REK Midt, St. Olavs Hospital,
Trondheim). All HUNT2 and HUNT3 participants gave a
written consent. A written consent was also given by those
who were evaluated with psychometric tests after
HUNT3, and individuals with dementia included from
nursing home. Due to the retrospective design of demen-
tia data collection from hospital, an informed consent for
inclusion was not possible.
Results
Characteristics of the study population are given in
Table 1. Compared to the sample of confirmed non-
demented, individuals who developed dementia were
older, had higher systolic BP and total HADS score, had
shorter education, and were more likely to be abstainers
from alcohol (Table 1).
From the dementia registry we identified 746 patients
(470 women) who had answered the headache questions
in HUNT2; 381 with AD, 121 with VaD, 69 with mixed
dementia (VaD + AD), and 175 with other types of
dementia.
In the final multivariate analyses, adjusted for gender,
age, education, smoking, HADS score and severe comor-
bid conditions, any headache was more likely to be re-
ported in HUNT2 among those who later were included
in the dementia registry (OR 1.24; 95 % CI 1.04–1.49)
compared to reference group, but less likely among the
confirmed non-demented individuals (OR 0.62; 95 % CI
0.39–0.98) (Table 2). This relationship was even stronger
for non-migrainous headache which was more likely to
be reported in HUNT2 among those who later were in-
cluded in the dementia registry (OR 1.49; 95 % CI 1.24–
1.80) compared to the reference group, but less likely
among the confirmed non-demented individuals (OR
Table 1 Characteristics of the study population at baseline in HUNT2
Confirmed non-demented Dementia HUNT3-participants aged 55–89 years
Participants 96 746 15,601
Women (%) 61.5 63.0 55.0
Mean age in years (SD) 61.8 (8.6) 71.3 (7.4) 56.3 (8.5)
Education >12 years (%) (missing = 106) 21.7 4.6 19.4
Current daily smoking (%) (missing = 11) 49.0 39.1 52.0
Mean body mass index (SD) 26.7 (3.2) 27.0 (4.2) 26.8 (3.8)
Mean systolic blood pressure (SD) 142.7 (17.7) 153.5 (23.0) 139.6 (19.9)
Mean total HADSa score (SD) 6.6 (3.8) 8.5 (5.2) 7.9 (5.5)
Abstainers from alcohol (%) (missing = 14) 10.4 33.2 11.5
Severe comorbidityb (%) 5.2 16.0 16.5
≥1 h hard physical activity (%) (missing = 214) 30.2 18.2 41.3
aHADS = Hospital Anxiety and Depression Scale
bSevere visual and/or auditive problems, severe psychiatric problems, score of ≥ 1 on the CAGE questionnaire indicating possible alcohol overuse, and/or
self-reported stroke
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0.50; 95 % CI 0.28–0.89) (Table 2). Such association was
not present for migraine, in fact migraine was less likely
among patients who developed dementia (OR 0.44; 95 %
CI 0.22–0.77) compared to controls (Table 2). Concern-
ing headache frequency, very few individuals with
headache ≥ 15 days/month at baseline developed demen-
tia (n = 21) or were included among the confirmed non-
demented (n = 3). No clear relationship was found be-
tween headache ≥ 15 days/month and dementia or being
confirmed non-demented (data not shown).
Regarding diagnoses of dementia, any headache and
non-migrainous headache were most clearly associated
with the development of vascular dementia and mixed
dementia (Table 2).
Discussion
Headache, in particular non-migrainous headache, was
more likely to be reported at baseline in HUNT2 among
those who later developed dementia, when compared to
the reference group. Conversely, headache and non-
migrainous headache were less likely to be reported in
HUNT2 among those who later were included in the
sample of confirmed non-demented.
In our previous paper based on 378 cases with demen-
tia, headache at baseline was associated with higher risk
of dementia (HR 1.3, 95 % 1.1–1.7) when considering all
individuals not included in a dementia registry as non-
demented [17]. The present study included a larger
number of dementia patients, and in addition a new sub-
group of dementia-free documented by tests of memory
and intelligence. The strongest association was found
between non-migrainous headache and dementia (OR
1.5, 95 % 1.2–1.8). The opposite relationship was found
between non-migrainous headache and the dementia-
free group, whereas no clear relationship was found be-
tween migraine and dementia.
Comparison with other studies
Few other registry studies have evaluated the association
between headache and the development of dementia. An
association between migraine and the occurrence of de-
mentia with Lewy bodies was found in a study linking
the Swedish dementia registry and the patient registry
[16]. However, although the results in previous studies
on migraine and cognitive decline have been somewhat
mixed, results from longitudinal studies consistently
have found that individuals with migraine are not at in-
creased risk of cognitive decline [9–15]. However, to the
best of our knowledge, no previous registry studies from
other countries have evaluated the relationship between
non-migrainous headache and dementia.
Strengths and limitations of the study
The major strengths of this study are the population-
based design and the use of validated headache diagno-
ses with good sensitivity and high specificity for both
migraine and non-migrainous headache [23]. The diag-
noses of dementia were verified in all patients by a team
of clinical experts in dementia. However, because the
diagnostic procedure differed in cases identified by the
hospital and nursing home, a limited number of specific
dementia diagnoses were used in the present study. The
group of confirmed non-demented underwent a medical
examination and were interviewed about their health
prior to the cognitive testing. In the multivariate ana-
lyses, we were able to adjust for a large number of po-
tential confounding factors. Nevertheless, the possibility
of residual confounding by unrecognized factors cannot
be wholly excluded.
There are also several study limitations that should be
considered. First, despite the large sample size, the group
of definite non-demented was relatively small. It should
be emphasized that a wide 95 % confidence intervals
was found for several analyses, and the results for these
analyses should be interpreted with caution, in particular
regarding migraine. Second, although 62 % of eligible
subjects participated in HUNT3, a selection bias cannot
be ruled out. Since the response rate of the headache
questions in HUNT2 was 56 % of the total adult popula-
tion in Nord-Trøndelag, one may question to what
Table 2 Prevalence ORa of any headache, migraine and non-migrainous headache related to status of confirmed non-demented or
four different groups dementia
Any headache Migraine Non-migrainous headache
Total number 16,443 6673 OR (95 % CI) 2003 OR (95 % CI) 4670 OR (95 % CI)
Unselected HUNT-population 15,601 6409 1.0 (Ref.) 1970 1.0 (Ref.) 4439 1.0 (Ref.)
Confirmed non-demented 96 25 0.62 (0.39–0.98) 11 0.89 (0.46–1.72) 14 0.50 (0.28–0.89)
Dementia, all types 746 239 1.24 (1.04–1.49) 22 0.44 (0.28–0.70) 217 1.49 (1.24–1.80)
Alzheimer’s disease 381 112 1.07 (0.95–1.37) 11 0.40 (0.22–0–77) 101 1.29 (1.00–1.67)
Vascular dementia 121 46 1.56 (1.06–2.36) 7 0.97 (0.43–2.16) 39 1.74 (1.16–2.61)
Mixed dementia 69 25 1.70 (1.02–2.84) 3 0.79 (0.24–2.60) 22 1.99 (1.17–3.38)
Other types of dementia 175 56 1.24 (0.89–1.74) 1 0.09 (0.01–0.62) 55 1.60 (1.14–2.25)
aAdjusted for age, gender, level of education, severe comorbidity, smoking and total HADS score
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degree the results can be generalized. Those who
responded to the headache questions were younger, were
more likely to be women and had higher socioeconomic
status than nonresponders On the other hand, the wide
scope of the HUNT studies makes participation bias
with specific relevance to headache less likely.
Interpretation
As stated in our previous paper [17], there are several
ways to interpret that any headache, and in particular
non-migrainous headache, were more likely to be reported
at baseline among those who developed dementia.
Firstly, we cannot rule out that for some individuals
early or presymptomatic condition of dementia was
causing headache, and not headache that later caused
dementia. Since all had managed to answer two ques-
tionnaires in HUNT2, it is not likely that any of them
had developed a dementia at this time. However, some
degree of mild cognitive impairment in some partici-
pants cannot be ruled out. For a total of 38 patients the
interval between reporting headache and the diagnosis
of dementia was less than five years. However, the mean
interval until diagnosis of dementia was nine years.
Secondly, headache and dementia may share an under-
lying causal factor, e.g., cardiovascular risk factors or al-
cohol overuse [24–28]. Even though non-migrainous
headache stood out as an independent associated factor
for dementia when adjusted for available environmental
factors, one cannot exclude the possibility for other
shared environmental factors or a shared underlying
genetic susceptibility [17].
Thirdly, it may be that headache is a true risk factor
for vascular dementia. It is of relevance that headache
status and the outcome “dementia” came from separate
registries, and knowledge of a relationship between de-
mentia and headache was missing when the dementia
registry was established. If headache is indeed a true risk
factor for dementia, the underlying mechanisms must be
elucidated. Furthermore, adding headache questions in
the clinical evaluation of cognitive function should also
be considered.
In the present study we found that headache and non-
migrainous headache were less likely to be reported
among those who later were included among confirmed
non-demented. We cannot rule out that this relationship
may be artificial. Although pain or headache in particu-
lar were not among exclusion criteria for selection of
this group, it may be that at least some individuals did
not want to participate in the memory and intelligence
test due to severe headache complaints that could cause
reduced test results [29]. In addition, it should be em-
phasized that only presumed healthy individuals without
severe comorbidity were invited to participate in the
memory and intelligence test. Although we adjusted for
presence of severe comorbidity in the multivariate ana-
lyses, the lower occurrence of non-migrainous headache
in HUNT2 among those who later were confirmed to be
non-demented could possibly be a consequence of lower
prevalence of other health problems.
No statistical significant association was found between
migraine and dementia in the present study. In accord-
ance, most longitudinal studies consistently have found
that individuals with migraine are not at increased risk of
cognitive decline [9–15]. This knowledge should give re-
assurance to migraine sufferers who fear that their attacks
could represent a risk factor of dementia in the long run.
Conclusions
Any headache and non-migrainous headache were more
likely to be reported at baseline among those who later
were included in a dementia registry. There was no clear
association between migraine and dementia. The sample
of confirmed non-demented were less likely to report
non-migrainous headache beforehand.
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